Global X Autonomous & Electric Vehicles vs Stryker Corporation — how do they compare? Global X Autonomous & Electric Vehicles trades at $32.79 (market cap $356.37M), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 298.1× Global X Autonomous & Electric Vehicles's market cap, and Stryker Corporation pays a 1.27% dividend while Global X Autonomous & Electric Vehicles pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X Autonomous & Electric Vehicles for 40 Days and Stryker Corporation for 21 Days on average.
| DRIV | SYK | |
|---|---|---|
Market Cap | $356.37M | $106.24B |
Volume | 22,397 | 2,982,001 |
Sector | Sector/Thematic | Health |
52-Week High | $42.53 | $388.35 |
52-Week Low | $27.58 | $269.75 |
Typical Hold Time | 40 Days | 21 Days |
Enterprise Value | — | $117.70B |
Dividend Yield | — | 1.27% |
Signals from Pluang's Aura AI — not financial advice
DRIV trades at $32.60, down 2.29% today amid mixed technical signals with a bullish overall signal but bearish moving averages. The stock shows neutral momentum oscillators with RSI at 51.36 indicating balanced buying and selling pressure. Recent automotive sector news highlights hybrid vehicle momentum and China's ambitious EV targets, potentially benefiting automotive-focused ETFs.
The stock faces near-term resistance at $34 with technical indicators suggesting consolidation. Automotive sector transformation creates both opportunities from EV/hybrid adoption and risks from oil price volatility. Market sentiment remains divided as investors weigh technological shifts against traditional automotive challenges.
Stryker (SYK) trades at $276.97, up 0.57% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 64.98% gross margins and 14.43% net income margin, though recent Q1 2026 earnings missed expectations. Analyst consensus remains strongly bullish with 71% buy ratings and $368.11 price target, representing 33% upside potential. Recent news highlights ongoing legal investigations regarding manufacturing issues that caused an 8.8% stock drop in September 2026.
SYK presents a compelling investment case with robust fundamentals and strong analyst support, though near-term headwinds from legal scrutiny and manufacturing challenges create uncertainty. The stock's current valuation at 28.7 P/E appears reasonable given growth prospects, but investors should monitor Q3 2026 earnings results on October 29 for confirmation of business recovery from recent setbacks.
Trailing returns across standard periods
Latest headlines on both assets
DRIV invests in companies involved in autonomous driving and electric vehicle production. It tracks the Solactive Autonomous & Electric Vehicles Index, focusing on software and hardware leaders like Tesla, NVIDIA, and Microsoft.
Read more on DRIV →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →